JPRN-UMIN000015926
Recruiting
N/A
Multicenter prospective study of peripheral arterial disease treatment
Keio University Hospital Department of Surgery0 sites5,500 target enrollmentDecember 12, 2014
ConditionsSymptomatic peripheral arterial disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Symptomatic peripheral arterial disease
- Sponsor
- Keio University Hospital Department of Surgery
- Enrollment
- 5500
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Patient diagnosed as symptomatic peripheral arterial disease and scheduled for revascularization
- •?For retrospective data accumulation, patients been diagnosed as symptomatic peripheral arterial disease and undergone revascularization before this study
Exclusion Criteria
- •?Patient who declined his/her consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary PreventionPeripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)NCT00689377AstraZeneca9,000
Completed
N/A
Prevalence of peripheral arterial disease in patients with coronary artery diseaseperipheral arterial disease (peripheral artery disease of lower limb, renal artery stenosis, carotid artery stenosis and abdominal aortic stenosis)JPRN-UMIN000002486Kokura Memorial Hospital2,000
Withdrawn
N/A
The outcome of a new vascular stent in patients with arterial disease in the legsPeripheral Arterial DiseaesFemoro-popliteal Arterial DiseaseChronic Limb IschaemiaClaudicationCritical Limb IschaemiaCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12618001310257Dr. Vikram Puttaswamy (Investigator)200
Completed
N/A
Etiology and Prevalence of Peripheral Arterial DiseaseCardiovascular DiseasesPeripheral Vascular DiseasesArterial Occlusive DiseasesNCT00005142National Heart, Lung, and Blood Institute (NHLBI)
Completed
Phase 3
Arterial Disease Multifactorial Intervention Trial (ADMIT)Arterial Occlusive DiseasesCardiovascular DiseasesHeart DiseasesVascular DiseasesDiabetes MellitusNCT00000539National Heart, Lung, and Blood Institute (NHLBI)